ArticleMolecular biology reports2025
Insights into inflammatory gene expression in endometriosis: a comparative evaluation of tissue biopsy samples.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveEndometriosis is a chronic inflammatory disorder characterized by ectopic growth of endometrial-like tissue. Cytokines play pivotal roles in coordinating tissue inflammation and immune responses. Therefore, some pro- and anti-inflammatory cytokines may be involved or altered in endometriosis were assessed in this study.
methodsThe expression levels of the reference gene ribosomal protein lateral stalk subunit P (RPLP) and interest genes, including interleukin 17 (IL-17), IL-23, IL-25, vascular endothelial growth factor (VEGF), and forkhead box P3 (FoxP3), were measured in the endometriotic tissues of 25 individuals with endometriosis and in the endometrial tissues of 25 control individuals. The cDNA was synthesized from the extracted RNAs, and these expression levels were analyzed using Real-time PCR.
resultsVEGF and FoxP3 were not expressed in endometriotic tissues, while non-endometriotic tissues in control group showed significant levels (VEGF: 4.41 × 10³±1.38 × 10³, FoxP3: 12.3 × 10³±4.18 × 10³; both P = 0.001). IL-17, IL-23, and IL-25 were not detected in either group. The RPLP was only expressed, indicating the presence of some viable active cells in this tissue, which was significantly lower than in controls (P = 0.001). The undetectable level of VEGF in endometriosis suggests that there was no active angiogenesis.
conclusionAccordingly, in endometriosis tissue, lymphocytes might be absent or not play a significant role, but the expression of the structural RPLP indicates the presence of some viable, active cells in this tissue. The roles of the immune system and angiogenesis are multidimensional, involved in different stages, from inflammation to immune tolerance. This underscores the importance of other growth factors, which require careful assessment and individualized treatment strategies to address each patient's specific needs.
Indexed as
Identifiers
40711490What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.